13-42900337-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_033255.5(EPSTI1):c.788C>T(p.Ala263Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000545 in 1,613,410 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_033255.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EPSTI1 | NM_033255.5 | c.788C>T | p.Ala263Val | missense_variant | 9/11 | ENST00000313624.12 | NP_150280.1 | |
LOC124903165 | XR_007063772.1 | n.116+2685G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EPSTI1 | ENST00000313624.12 | c.788C>T | p.Ala263Val | missense_variant | 9/11 | 1 | NM_033255.5 | ENSP00000318643 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000724 AC: 11AN: 151970Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251280Hom.: 0 AF XY: 0.0000810 AC XY: 11AN XY: 135814
GnomAD4 exome AF: 0.0000527 AC: 77AN: 1461440Hom.: 0 Cov.: 31 AF XY: 0.0000468 AC XY: 34AN XY: 727034
GnomAD4 genome AF: 0.0000724 AC: 11AN: 151970Hom.: 0 Cov.: 31 AF XY: 0.0000809 AC XY: 6AN XY: 74198
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 15, 2024 | The c.821C>T (p.A274V) alteration is located in exon 10 (coding exon 10) of the EPSTI1 gene. This alteration results from a C to T substitution at nucleotide position 821, causing the alanine (A) at amino acid position 274 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at